Maharashtra FDA registers 26 not-of-standard drugs in January

Mumbai, 10 Feb: The Maharashtra Food and Drugs Administration (FDA) has detected 26 not-of-standard drugs during the month of January in the random sample testing. In January manufacturers from the tax-free state of Himachal Pradesh with 13 accounts for the major share. Well-known drug manufacturers like Affy Parentrals for cavmox, amoxycillin and POT.CLA.oral suspension, Clevus Lifesciences for cardin tablets, Galpha Laboratories for Soulfer XT tablets, Ind-Swift Ltd. for Rabifin-20 (rabeprazole tablets IP), Akums Drugs and Pharmaceuticals for AC syrup and MED Manor Organics for zincold plus tablets figure in the list. One of the highlights of Maharashtra FDA's samples this time is that some of them do not comply with the IP requirements. They are Shaimil Laboratories (Petiol-40), Alliance Biotech (Rayzol-D Rabeprazole and Domperidone tablets), Biogenetic Drugs (Maxi Forte Mefenamic acis and Paracetamol tablets), Clevus LifeSciences (Cardin tablets), Magma Allianz Laboratories (Pancard, Pantoprazole tablets), Pacific India (Gopan), Shervotec Pharmaceuticals (Aurobid-500/Ciprofloxacin tablets), Tirupati Medicare (Diecold tablets), Ind-Swift Ltd. (Rabifin-20 rabeprazole tablets IP), Surien Pharmaceuticals (Angifine 10 SR Nifedipine sustained release tablets), Ruby Organics (Methylan capsules) and Technica & Pharma Pvt Ltd. (Pantec-D tablets). According to the latest data released by the Maharashtra FDA, out of 26 such drug samples 13 are from Himachal Pradesh, 4 from Uttaranchal, 2 from Maharashtra and one each from Andhra Pradesh, Bihar, Gujarat, Jammu & Kashmir, Madhya Pradesh, Pondicherry and Uttar Pradesh. During January, the companies in the list includes: Affy Parentrals, Alliance Biotech, Biogenetic Drugs, Clevus LifeSciences, Magma Allianz Laboratories, Pacific India, Galpha Laboratories, Laborate Pharmaceuticals, Rahul Pharmaceuticals, Shervotec Pharmaceuticals, Shiva Biogenetic, Tirupati Medicare and Unison Pharmaceuticals from Himachal Pradesh, Akums Drugs and Pharmaceuticals, MED Manor Organics, Shreya LifeSciences and Technica & Pharma from Uttaranchal, Siddhi Herbal and Ruby Organics from Maharashtra, Sangam Healthcare Products from Andhra Pradesh, Renovision Exports from Bihar, Shaimil Laboratories from Gujarat, Ind-Swift Ltd. from Jammu & Kashmir, Pharma Asia Drug from Madhya Pradesh, Surien Pharmaceuticals from Pondichery and Godjay Laboratories from Uttar Pradesh. The state FDA routinely picks up random samples of drugs from chemists and druggists and send for testing. The department will soon issue show cause notices to these companies.

Pharmabiz